Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
125.82
+2.09 (1.69%)
At close: Dec 26, 2024, 4:00 PM
125.00
-0.82 (-0.65%)
After-hours: Dec 26, 2024, 7:36 PM EST
Jazz Pharmaceuticals Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for JAZZ stock have an average target of 173.93, with a low estimate of 113 and a high estimate of 230. The average target predicts an increase of 38.24% from the current stock price of 125.82.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for JAZZ stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 5 | 5 | 5 | 5 |
| Buy | 7 | 7 | 6 | 6 | 6 | 6 |
| Hold | 3 | 4 | 4 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 15 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $163 | Buy | Reiterates | $163 | +29.55% | Dec 12, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $179 | Buy | Reiterates | $179 | +42.27% | Dec 12, 2024 |
| Needham | Needham | Strong Buy Reiterates $207 | Strong Buy | Reiterates | $207 | +64.52% | Dec 12, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $179 | Buy | Reiterates | $179 | +42.27% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $200 | Strong Buy | Reiterates | $200 | +58.96% | Nov 22, 2024 |
Financial Forecast
Revenue This Year
4.12B
from 3.83B
Increased by 7.51%
Revenue Next Year
4.40B
from 4.12B
Increased by 6.82%
EPS This Year
20.75
from 6.10
Increased by 240.09%
EPS Next Year
22.24
from 20.75
Increased by 7.19%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 4.3B | 4.8B | 5.1B | |||
| Avg | 4.1B | 4.4B | 4.6B | |||
| Low | 3.9B | 3.9B | 4.0B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 11.7% | 15.7% | 16.0% | |||
| Avg | 7.5% | 6.8% | 4.3% | |||
| Low | 2.4% | -5.0% | -9.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 21.59 | 25.45 | 26.41 | |||
| Avg | 20.75 | 22.24 | 22.95 | |||
| Low | 19.66 | 18.17 | 17.13 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 253.8% | 22.7% | 18.7% | |||
| Avg | 240.1% | 7.2% | 3.2% | |||
| Low | 222.2% | -12.4% | -23.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.